NEW YORK--(BUSINESS WIRE)--Lescarden Inc. (LCAR:OB) announced today that it had entered into an agreement with NanoASIA Company Limited of Bangkok, Thailand granting NanoAsia a 10 year exclusive license to market Lescarden’s proprietary product, CATRIX® WOUND DRESSING in Thailand and Malaysia.
